show add
hide add

GI197111X


Hair Loss Treatment Type:

Dual 5-alpha reductase inhibitor in an oral softgel

 

Notes:

GI197111X is a new dual 5-alpha reductase inhibitor which could be GlaxoSmithKline’s successor to Dutasteride / Avodart. Because Glaxo already has a potent dual 5-alpha reductase inhibitor on the market (Avodart), there is no reason to conduct Phase I or II FDA clinical trials unless they believe it is superior to their existing marketed medicine for some reason.

 

Availability:

Last reported in small scale clinical trials (FDA Phase I/II)

 




READ THIS NEXT

    Shampoo for Women

    Blonde girl worried about hair loss

    ProTHIK Spray

    Tagamet (Cimetidine)

    Hair Loss Treatment

    man controls hair loss and unhappy gazing at you in the mirror 685775544 bald, baldness, loosing, prevention, hearttrob

    Male Pattern Alopecia